[HTML][HTML] Biomarkers in Thyroid Cancer: Emerging Opportunities from Non-Coding RNAs and Mitochondrial Space
Thyroid cancer diagnosis primarily relies on imaging techniques and cytological analyses. In
cases where the diagnosis is uncertain, the quantification of molecular markers has been …
cases where the diagnosis is uncertain, the quantification of molecular markers has been …
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review
The increasing prevalence of thyroid cancer emphasizes the need for a thorough
assessment of risk of malignancy in Bethesda III nodules. Various methods ranging …
assessment of risk of malignancy in Bethesda III nodules. Various methods ranging …
Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with …
CA Munoz-Zuluaga, JJ Heymann… - American Journal of …, 2024 - academic.oup.com
Objectives Afirma has recently introduced its Xpression Atlas (XA) as an adjunct to its
Genomic Sequencing Classifier (GSC) for risk stratification of cytologically indeterminate …
Genomic Sequencing Classifier (GSC) for risk stratification of cytologically indeterminate …
Diagnostic interobserver agreement for thyroid fine-needle aspirates: Effects of reviewer experience and molecular diagnostics
HN Gokozan, M Mostyka… - American Journal of …, 2024 - academic.oup.com
Objectives Few cytologically indeterminate thyroid fine-needle aspirations (FNAs) harbor
BRAF V600E. Here, we assess interobserver agreement for The Bethesda System for …
BRAF V600E. Here, we assess interobserver agreement for The Bethesda System for …